These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 17595758)
21. pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel. Shim WS; Kim JH; Kim K; Kim YS; Park RW; Kim IS; Kwon IC; Lee DS Int J Pharm; 2007 Feb; 331(1):11-8. PubMed ID: 17049773 [TBL] [Abstract][Full Text] [Related]
22. Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings. Li D; Yang K; Li JS; Ke XY; Duan Y; Du R; Song P; Yu KF; Ren W; Huang D; Li XH; Hu X; Zhang X; Zhang Q Int J Nanomedicine; 2012; 7():6105-14. PubMed ID: 23269869 [TBL] [Abstract][Full Text] [Related]
23. Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules. Kamei T; Kitayama J; Yamaguchi H; Soma D; Emoto S; Konno T; Ishihara K; Ishigami H; Kaisaki S; Nagawa H Cancer Sci; 2011 Jan; 102(1):200-5. PubMed ID: 20942868 [TBL] [Abstract][Full Text] [Related]
24. Paclitaxel loaded nano-aggregates based on pH sensitive polyaspartamide amphiphilic graft copolymers. Seo K; Chung SW; Byun Y; Kim D Int J Pharm; 2012 Mar; 424(1-2):26-32. PubMed ID: 22226879 [TBL] [Abstract][Full Text] [Related]
25. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model. Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913 [TBL] [Abstract][Full Text] [Related]
26. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel. Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538 [TBL] [Abstract][Full Text] [Related]
27. Aggregation properties of a polymeric anticancer therapeutic: a coarse-grained modeling study. Peng LX; Yu L; Howell SB; Gough DA J Chem Inf Model; 2011 Dec; 51(12):3030-5. PubMed ID: 21995420 [TBL] [Abstract][Full Text] [Related]
28. Skin ulceration potential of paclitaxel in a mouse skin model in vivo. Dorr RT; Snead K; Liddil JD Cancer; 1996 Jul; 78(1):152-6. PubMed ID: 8646711 [TBL] [Abstract][Full Text] [Related]
29. Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. Hua MY; Yang HW; Chuang CK; Tsai RY; Chen WJ; Chuang KL; Chang YH; Chuang HC; Pang ST Biomaterials; 2010 Oct; 31(28):7355-63. PubMed ID: 20609471 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of 2-methacryloyloxyethyl phosphorylcholine polymeric nanoparticle for immunoassay of C-reactive protein detection. Park J; Kurosawa S; Watanabe J; Ishihara K Anal Chem; 2004 May; 76(9):2649-55. PubMed ID: 15117211 [TBL] [Abstract][Full Text] [Related]
31. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel. Luo LM; Huang Y; Zhao BX; Zhao X; Duan Y; Du R; Yu KF; Song P; Zhao Y; Zhang X; Zhang Q Biomaterials; 2013 Jan; 34(4):1102-14. PubMed ID: 23127332 [TBL] [Abstract][Full Text] [Related]
32. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model. Franco MS; Roque MC; de Barros ALB; de Oliveira Silva J; Cassali GD; Oliveira MC Biomed Pharmacother; 2019 Jan; 109():1728-1739. PubMed ID: 30551427 [TBL] [Abstract][Full Text] [Related]
33. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor. Sheihet L; Garbuzenko OB; Bushman J; Gounder MK; Minko T; Kohn J Eur J Pharm Sci; 2012 Feb; 45(3):320-9. PubMed ID: 22155544 [TBL] [Abstract][Full Text] [Related]
34. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity. Shikanov A; Vaisman B; Krasko MY; Nyska A; Domb AJ J Biomed Mater Res A; 2004 Apr; 69(1):47-54. PubMed ID: 14999750 [TBL] [Abstract][Full Text] [Related]
35. Improved antitumor effect of paclitaxel administered in vivo as pH and glutathione-sensitive nanohydrogels. Pérez E; Martínez A; Teijón C; Olmo R; Teijón JM; Blanco MD Int J Pharm; 2015 Aug; 492(1-2):10-9. PubMed ID: 26160666 [TBL] [Abstract][Full Text] [Related]
36. Selection suitable solvents to prepare paclitaxel-loaded micelles by solvent evaporation method. Jiao Z; Liu N; Chen Z Pharm Dev Technol; 2012; 17(2):164-9. PubMed ID: 20977318 [TBL] [Abstract][Full Text] [Related]
37. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666 [TBL] [Abstract][Full Text] [Related]
38. Conjugated chitosan as a novel platform for oral delivery of paclitaxel. Lee E; Lee J; Lee IH; Yu M; Kim H; Chae SY; Jon S J Med Chem; 2008 Oct; 51(20):6442-9. PubMed ID: 18826299 [TBL] [Abstract][Full Text] [Related]
39. Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA. Yu YH; Kim E; Park DE; Shim G; Lee S; Kim YB; Kim CW; Oh YK Eur J Pharm Biopharm; 2012 Feb; 80(2):268-73. PubMed ID: 22108492 [TBL] [Abstract][Full Text] [Related]
40. [Solubilizing and sustained-releasing abilities and safety preliminary evaluation for paclitaxel based on N-octyl-O, N-carboxymethyl chitosan polymeric micelles]. Huo MR; Zhang Y; Zhou JP; Lü L; Liu H; Liu FJ Yao Xue Xue Bao; 2008 Aug; 43(8):855-61. PubMed ID: 18956780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]